Overexpression of MIEN1 and TRAF4 has been reported in various cancers and functionally regulates the PI3K/AKT pathway to promote tumorigenesis40,41, and therefore, this overexpression may contribute to the dysregulated PI3K/AKT signaling pathway observed in refractory MCLs. This evidence concerns the gene AKT1 and cancer.